anastrozole has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Lung cancer is the most common cancer in the world." | 1.33 | Aromatase inhibitors in human lung cancer therapy. ( Dubinett, SM; Fishbein, MC; Garban, HJ; Goodglick, L; Marquez-Garban, DC; Pietras, RJ; Weinberg, OK, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shen, L | 1 |
Li, Z | 2 |
Shen, S | 1 |
Niu, X | 1 |
Yu, Y | 1 |
Liao, M | 1 |
Chen, Z | 1 |
Lu, S | 1 |
Weinberg, OK | 1 |
Marquez-Garban, DC | 1 |
Fishbein, MC | 1 |
Goodglick, L | 1 |
Garban, HJ | 1 |
Dubinett, SM | 1 |
Pietras, RJ | 1 |
2 other studies available for anastrozole and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Carcinoma, Non-Small-Cell Lung; | 2012 |
Aromatase inhibitors in human lung cancer therapy.
Topics: Anastrozole; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Carcinoma, Non-Small-Cell Lu | 2005 |